banner image

Functional constipation (2 years of age and older) mechanism of action

Not actual patients.

LINZESS increases fluid secretion and GI motility1-3,*

LINZESS is a peptide that stimulates the guanylate cyclase-C (GC-C) receptor1,2,*

Diagram showing LINZESS binding to guanylate cyclase-C receptors, increasing cyclic GMP and stimulating chloride and bicarbonate secretion into the intestinal lumen, resulting in increased intestinal fluid and accelerated transit
LINZESS acts locally within the GI tract and has negligible 
systemic availability1

CFTR, cystic fibrosis transmembrane conductance regulator; cGMP, cyclic guanosine monophosphate; GI, gastrointestinal.

*Based on nonclinical studies. Systemic exposure of drug and active metabolite are negligible following oral administration.1

†LINZESS activates GC-C receptors and stimulates secretion of electrolytes into the lumen of the intestine via activation of CFTR, which results in increased intestinal fluid content and accelerated transit.1